M
Metagenomi Therapeutics, Inc. (MGX)
NMS – Real vaqt narxi. Valyuta: USD
1.35
0.00 (0.00%)
Yopilishda: May 12, 2026, 4:00 PM EDT
Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling
Find any stock by ticker or company name
NMS – Real vaqt narxi. Valyuta: USD
1.35
0.00 (0.00%)
Yopilishda: May 12, 2026, 4:00 PM EDT
Metagenomi Therapeutics, Inc. AQShda joylashgan in vivo gen tahriri kompaniyasi bo'lib, davolash genetik dori vositalarini ishlab chiqadi. Kompaniyaning asosiy ishlab chiqish dasturi MGX-001 gemofiliya bilan kasallangan kattalar va bolalarda qon ketishi va bo'g'imlarning shikastlanishidan umrbod himoya qilish uchun mo'ljallangan. U Ionis Pharmaceuticals, Inc. bilan gipertrigliseridemiya, transtiretin amiloidozi uchun transtiretin (TTR), refrakter gipertenziya uchun angiotensinogen (AGT) va boshqa dasturlarni davolash bo'yicha hamkorlik shartnomasiga ega. Kompaniya ilgari Metagenomi, Inc. nomi bilan tanilgan va 2026 yil yanvar oyida Metagenomi Therapeutics, Inc. nomini o'zgartirgan. Metagenomi Therapeutics, Inc. 2016 yilda tashkil etilgan va shtab-kvartirasi Kaliforniyaning Emirevill shahrida joylashgan.
| Ism | Lavozim |
|---|---|
| Dr. Alan Brooks Ph.D. | Senior Vice President of Research |
| Dr. Brian Charles Thomas Ph.D. | Co-Founder & Director |
| Dr. Jian Irish M.B.A., Ph.D. | CEO, President & Director |
| Dr. Joseph Knowles M.D. | Co-Founder & Member of Scientific Advisory Board |
| Mr. Mark Leonard | Senior Vice President of Technical Development & Operations |
| Mr. Matthew L. Wein J.D. | General Counsel, Compliance Officer, Head of BD&L and Corporate Secretary |
| Ms. Katalin Kauser M.D., Ph.D. | Senior Vice President of Translational Biology |
| Ms. Pamela M. Wapnick M.B.A. | Chief Financial Officer |
| Sana | Turi | Hujjat |
|---|---|---|
| 2026-05-11 | 10-Q | mgx-20260331.htm |
| 2026-04-27 | DEF 14A | mgx-20260421.htm |
| 2026-03-05 | S-8 | mgx-20260305.htm |
| 2026-01-12 | 8-K | mgx-20260112.htm |
| 2025-11-12 | 8-K | mgx-20251111.htm |
| 2025-11-12 | 10-Q | mgx-20250930.htm |
| 2025-10-01 | 8-K | mgx-20250929.htm |
| 2025-08-12 | 8-K | mgx-20250812.htm |
| 2025-08-12 | 10-Q | mgx-20250630.htm |
| 2025-06-11 | 8-K | mgx-20250610.htm |